Further intersecting these predicted targets with transcriptomic datasets from breast, colorectal, and lung cancers highlighted hub proteins such as TYMS, AURKA, CDK1, and TK-1, which are critical regulators of DNA synthesis, mitotic progression, and cell cycle checkpoints. Here, AURKA is linked to lung carcinoma.